Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Characteristics, Attitudes and Experiences of Individuals Using Injectable Semaglutide for Obesity Management: An Interim Analysis of the OUTSTEP 1 Study
Authors:
Michael Vallis1; Salah Abusnana2; Jennifer L. Baker3; Andreea Ciudin4-7; Leyla Hernandez Donoso8; Sandra Elia9; Dmitry Estulin8; Bruno Halpern10; 11; Samantha Hocking12; Hyuk-Sang Kwon13; Susanne Reger-Tan14; Ricardo Reynoso8; Hanen Samouda15; 16; Arya M. Sharma17